Literature DB >> 21466943

Research to practice in addiction treatment: key terms and a field-driven model of technology transfer.

.   

Abstract

The transfer of new technologies (e.g., evidence-based practices) into substance abuse treatment organizations often occurs long after they have been developed and shown to be effective. Transfer is slowed, in part, due to a lack of clear understanding about all that is needed to achieve full implementation of these technologies. Such misunderstanding is exacerbated by inconsistent terminology and overlapping models of an innovation, including its development and validation, dissemination to the public, and implementation or use in the field. For this reason, a workgroup of the Addiction Technology Transfer Center (ATTC) Network developed a field-driven conceptual model of the innovation process that more precisely defines relevant terms and concepts and integrates them into a comprehensive taxonomy. The proposed definitions and conceptual framework will allow for improved understanding and consensus regarding the distinct meaning and conceptual relationships between dimensions of the technology transfer process and accelerate the use of evidence-based practices.
Copyright © 2011 Elsevier Inc. All rights reserved.

Mesh:

Year:  2011        PMID: 21466943     DOI: 10.1016/j.jsat.2011.02.006

Source DB:  PubMed          Journal:  J Subst Abuse Treat        ISSN: 0740-5472


  8 in total

1.  Technology transfer for the implementation of a clinical trials network on drug abuse and mental health treatment in Mexico.

Authors:  Viviana E Horigian; Rodrigo A Marín-Navarrete; Rosa E Verdeja; Elizabeth Alonso; María A Perez; José Fernández-Mondragón; Carlos Berlanga; María Elena Medina-Mora; José Szapocznik
Journal:  Rev Panam Salud Publica       Date:  2015-09

2.  The transition to medication adoption in publicly funded substance use disorder treatment programs: organizational structure, culture, and resources.

Authors:  Hannah K Knudsen; Paul M Roman
Journal:  J Stud Alcohol Drugs       Date:  2014-05       Impact factor: 2.582

Review 3.  The global movement towards a public health approach to substance use disorders.

Authors:  Kimberly Johnson; Irina Pinchuk; Marie Isabel E Melgar; Martin Osayande Agwogie; Fernando Salazar Silva
Journal:  Ann Med       Date:  2022-12       Impact factor: 5.348

4.  Comparing two federal financing strategies on penetration and sustainment of the adolescent community reinforcement approach for substance use disorders: protocol for a mixed-method study.

Authors:  Alex R Dopp; Sarah B Hunter; Mark D Godley; Chau Pham; Bing Han; Rosanna Smart; Jonathan Cantor; Beau Kilmer; Grace Hindmarch; Isabelle González; Lora L Passetti; Kelli L Wright; Gregory A Aarons; Jonathan Purtle
Journal:  Implement Sci Commun       Date:  2022-05-13

5.  Innovation attributes and adoption decisions: perspectives from leaders of a national sample of addiction treatment organizations.

Authors:  Hannah K Knudsen; Paul M Roman
Journal:  J Subst Abuse Treat       Date:  2014-08-23

6.  Brief Strategic Family Therapy: implementing evidence-based models in community settings.

Authors:  José Szapocznik; Joan A Muir; Johnathan H Duff; Seth J Schwartz; C Hendricks Brown
Journal:  Psychother Res       Date:  2013-11-26

Review 7.  A systematic review of implementation frameworks of innovations in healthcare and resulting generic implementation framework.

Authors:  Joanna C Moullin; Daniel Sabater-Hernández; Fernando Fernandez-Llimos; Shalom I Benrimoj
Journal:  Health Res Policy Syst       Date:  2015-03-14

8.  Virtual training and technical assistance: a shift in behavioral health workforce access and perceptions of services during emergency restrictions.

Authors:  Kristen G Powell; Michael J Chaple; Maxine Henry; Cory Morton; Sara J Becker; Heather J Gotham; Holly N Hagle; Ashley C Helle; Laurie J Krom; Rosemarie Martin; Todd D Molfenter; Nancy Roget; Beth A Rutkowski; Isa I Velez-Echevarria; Ruth Yanez
Journal:  BMC Med Educ       Date:  2022-07-27       Impact factor: 3.263

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.